Logo image of SHL.DE

SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:SHL - DE000SHL1006 - Common Stock

44.46 EUR
-0.26 (-0.58%)
Last: 12/19/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, SHL scores 5 out of 10 in our fundamental rating. SHL was compared to 66 industry peers in the Health Care Equipment & Supplies industry. SHL has a medium profitability rating, but doesn't score so well on its financial health evaluation. SHL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

SHL had positive earnings in the past year.
SHL had a positive operating cash flow in the past year.
SHL had positive earnings in each of the past 5 years.
Each year in the past 5 years SHL had a positive operating cash flow.
SHL.DE Yearly Net Income VS EBIT VS OCF VS FCFSHL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

SHL has a Return On Assets of 4.83%. This is in the better half of the industry: SHL outperforms 66.67% of its industry peers.
With a decent Return On Equity value of 11.88%, SHL is doing good in the industry, outperforming 69.70% of the companies in the same industry.
SHL has a better Return On Invested Capital (7.65%) than 62.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 9.66%.
The 3 year average ROIC (6.28%) for SHL is below the current ROIC(7.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.83%
ROE 11.88%
ROIC 7.65%
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
SHL.DE Yearly ROA, ROE, ROICSHL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

The Profit Margin of SHL (9.17%) is better than 66.67% of its industry peers.
SHL's Profit Margin has been stable in the last couple of years.
SHL has a Operating Margin of 13.53%. This is in the better half of the industry: SHL outperforms 63.64% of its industry peers.
In the last couple of years the Operating Margin of SHL has remained more or less at the same level.
The Gross Margin of SHL (38.63%) is worse than 77.27% of its industry peers.
SHL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.53%
PM (TTM) 9.17%
GM 38.63%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
SHL.DE Yearly Profit, Operating, Gross MarginsSHL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

SHL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SHL has less shares outstanding
The number of shares outstanding for SHL has been increased compared to 5 years ago.
The debt/assets ratio for SHL has been reduced compared to a year ago.
SHL.DE Yearly Shares OutstandingSHL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SHL.DE Yearly Total Debt VS Total AssetsSHL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 2.05 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
SHL's Altman-Z score of 2.05 is in line compared to the rest of the industry. SHL outperforms 42.42% of its industry peers.
SHL has a debt to FCF ratio of 5.45. This is a neutral value as SHL would need 5.45 years to pay back of all of its debts.
SHL's Debt to FCF ratio of 5.45 is in line compared to the rest of the industry. SHL outperforms 50.00% of its industry peers.
SHL has a Debt/Equity ratio of 0.63. This is a neutral value indicating SHL is somewhat dependend on debt financing.
SHL has a Debt to Equity ratio of 0.63. This is in the lower half of the industry: SHL underperforms 69.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 5.45
Altman-Z 2.05
ROIC/WACC1.23
WACC6.21%
SHL.DE Yearly LT Debt VS Equity VS FCFSHL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

SHL has a Current Ratio of 1.11. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SHL (1.11) is worse than 71.21% of its industry peers.
A Quick Ratio of 0.79 indicates that SHL may have some problems paying its short term obligations.
SHL has a Quick ratio of 0.79. This is in the lower half of the industry: SHL underperforms 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.79
SHL.DE Yearly Current Assets VS Current LiabilitesSHL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.17% over the past year.
The Earnings Per Share has been growing by 11.29% on average over the past years. This is quite good.
SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.53%.
The Revenue has been growing by 10.08% on average over the past years. This is quite good.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%

3.2 Future

The Earnings Per Share is expected to grow by 8.79% on average over the next years. This is quite good.
SHL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.85% yearly.
EPS Next Y1.78%
EPS Next 2Y6.58%
EPS Next 3Y8.95%
EPS Next 5Y8.79%
Revenue Next Year3.08%
Revenue Next 2Y4.57%
Revenue Next 3Y5.17%
Revenue Next 5Y5.85%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SHL.DE Yearly Revenue VS EstimatesSHL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
SHL.DE Yearly EPS VS EstimatesSHL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.60 indicates a rather expensive valuation of SHL.
Compared to the rest of the industry, the Price/Earnings ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 80.30% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.38. SHL is valued slightly cheaper when compared to this.
SHL is valuated rather expensively with a Price/Forward Earnings ratio of 18.28.
60.61% of the companies in the same industry are more expensive than SHL, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SHL to the average of the S&P500 Index (23.83), we can say SHL is valued slightly cheaper.
Industry RankSector Rank
PE 18.6
Fwd PE 18.28
SHL.DE Price Earnings VS Forward Price EarningsSHL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 60.61% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, SHL is valued a bit cheaper than the industry average as 78.79% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.48
EV/EBITDA 13.93
SHL.DE Per share dataSHL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SHL does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SHL may justify a higher PE ratio.
PEG (NY)10.47
PEG (5Y)1.65
EPS Next 2Y6.58%
EPS Next 3Y8.95%

6

5. Dividend

5.1 Amount

SHL has a Yearly Dividend Yield of 2.24%.
Compared to an average industry Dividend Yield of 1.16, SHL pays a better dividend. On top of this SHL pays more dividend than 80.30% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, SHL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.24%

5.2 History

The dividend of SHL has a limited annual growth rate of 4.38%.
Dividend Growth(5Y)4.38%
Div Incr Years0
Div Non Decr Years6
SHL.DE Yearly Dividends per shareSHL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

SHL pays out 49.72% of its income as dividend. This is a bit on the high side, but may be sustainable.
SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.72%
EPS Next 2Y6.58%
EPS Next 3Y8.95%
SHL.DE Yearly Income VS Free CF VS DividendSHL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
SHL.DE Dividend Payout.SHL.DE Dividend Payout, showing the Payout Ratio.SHL.DE Dividend Payout.PayoutRetained Earnings

SIEMENS HEALTHINEERS AG

FRA:SHL (12/19/2025, 7:00:00 PM)

44.46

-0.26 (-0.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-05 2026-02-05
Inst Owners12.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap50.15B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts80
Price Target56.61 (27.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.24%
Yearly Dividend0.95
Dividend Growth(5Y)4.38%
DP49.72%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-6.61%
PT rev (3m)-8.52%
EPS NQ rev (1m)1.03%
EPS NQ rev (3m)-8.32%
EPS NY rev (1m)-4.69%
EPS NY rev (3m)-7.09%
Revenue NQ rev (1m)0.45%
Revenue NQ rev (3m)1.66%
Revenue NY rev (1m)-1.1%
Revenue NY rev (3m)-1.45%
Valuation
Industry RankSector Rank
PE 18.6
Fwd PE 18.28
P/S 2.15
P/FCF 18.48
P/OCF 14.2
P/B 2.78
P/tB N/A
EV/EBITDA 13.93
EPS(TTM)2.39
EY5.38%
EPS(NY)2.43
Fwd EY5.47%
FCF(TTM)2.41
FCFY5.41%
OCF(TTM)3.13
OCFY7.04%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)10.47
PEG (5Y)1.65
Graham Number29.33
Profitability
Industry RankSector Rank
ROA 4.83%
ROE 11.88%
ROCE 9.97%
ROIC 7.65%
ROICexc 8.31%
ROICexgc 43.54%
OM 13.53%
PM (TTM) 9.17%
GM 38.63%
FCFM 11.61%
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.75%
ROICexc(5y)6.62%
ROICexgc(3y)33.94%
ROICexgc(5y)34.43%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y11.98%
ROICexgc growth 5Y11.06%
ROICexc growth 3Y9.08%
ROICexc growth 5Y-1.26%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 5.45
Debt/EBITDA 2.54
Cap/Depr 63.12%
Cap/Sales 3.5%
Interest Coverage 7.04
Cash Conversion 79.23%
Profit Quality 126.59%
Current Ratio 1.11
Quick Ratio 0.79
Altman-Z 2.05
F-Score8
WACC6.21%
ROIC/WACC1.23
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y1.78%
EPS Next 2Y6.58%
EPS Next 3Y8.95%
EPS Next 5Y8.79%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year3.08%
Revenue Next 2Y4.57%
Revenue Next 3Y5.17%
Revenue Next 5Y5.85%
EBIT growth 1Y12.53%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year35.66%
EBIT Next 3Y17.7%
EBIT Next 5Y14.23%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%

SIEMENS HEALTHINEERS AG / SHL.DE FAQ

What is the fundamental rating for SHL stock?

ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.


What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for SIEMENS HEALTHINEERS AG?

SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for SHL stock?

The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 18.6 and the Price/Book (PB) ratio is 2.78.


Can you provide the dividend sustainability for SHL stock?

The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.72%.